Terry L Ng - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Terry L Ng

Showing results (11-20 of 41) with videos related to

Pageof 5

Sort By:

Journal of Bone Oncology|December 9, 2020

Real-world practice patterns and attitudes towards de-escalation of bone-modifying agents in patients with bone metastases from breast and prostate cancer: A physician surveyMashari AlZahrani, Mark Clemons, Lisa Vandermeer, et al.

Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 21, 2022

Symptomatic skeletal-related events in patients receiving longer term bone-modifying agents for bone metastases from breast and castration resistant prostate cancersMashari Alzahrani, Carol Stober, Michelle Liu, et al.

Current Opinion in Supportive and Palliative Care|February 13, 2025

Assessment of the benefits of bone modifying agents in the management of advanced breast, prostate, and lung cancersJennifer Leigh, Shing Fung Lee, Ali Fawaz, et al.

Bladder Cancer (Amsterdam, Netherlands)|December 28, 2020

Molecular Biomarkers of Response to PD-1/ PD-L1 Immune Checkpoint Blockade in Advanced Bladder CancerMegan M Tu, Terry L Ng, Florus C De Jong, et al.

Breast Cancer Research and Treatment|May 19, 2024

Development and application of a weighted change score to evaluate interventions for vasomotor symptoms in patients with breast cancer using regression trees: a cohort studyKatherine Marie Cole, Sharon McGee, Mark Clemons, et al.

The Oncologist|July 24, 2024

Patients' considerations of time toxicity when assessing cancer treatments with marginal benefitArjun Gupta, Michael D Brundage, Jacqueline Galica, et al.

Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 11, 2020

Prospective Observational Study Revealing Early Pulmonary Function Changes Associated With Brigatinib InitiationTerry L Ng, Amber Johnson, Raphael A Nemenoff, et al.

Critical Reviews in Oncology/Hematology|November 22, 2021

The current landscape of systemic therapy for recurrent glioblastoma: A systematic review of randomized-controlled trialsFrancesco G T Fazzari, Foster Rose, Mehrnoosh Pauls, et al.

Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 14, 2025

Efficacy of cannabinoids for the prophylaxis of chemotherapy-induced nausea and vomiting-a systematic review and meta-analysisRonald Chow, Anna Basu, Jagdeep Kaur, et al.

Eclinicalmedicine|January 16, 2026

Pneumocystis jirovecii pneumonia prophylaxis in patients with glioma receiving concurrent chemoradiation: a systematic review and meta-analysisJason L Jia, Bader Alshamsan, Ana Beltran-Bless, et al.

Pageof 5

Search research articles

Showing results (11-20 of 41) with videos related to

Sort By:

Pageof 5

Journal of Bone Oncology|December 9, 2020

Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 21, 2022

Current Opinion in Supportive and Palliative Care|February 13, 2025

Assessment of the benefits of bone modifying agents in the management of advanced breast, prostate, and lung cancersJennifer Leigh, Shing Fung Lee, Ali Fawaz, et al.

Bladder Cancer (Amsterdam, Netherlands)|December 28, 2020

Molecular Biomarkers of Response to PD-1/ PD-L1 Immune Checkpoint Blockade in Advanced Bladder CancerMegan M Tu, Terry L Ng, Florus C De Jong, et al.

Breast Cancer Research and Treatment|May 19, 2024

The Oncologist|July 24, 2024

Patients' considerations of time toxicity when assessing cancer treatments with marginal benefitArjun Gupta, Michael D Brundage, Jacqueline Galica, et al.

Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 11, 2020

Prospective Observational Study Revealing Early Pulmonary Function Changes Associated With Brigatinib InitiationTerry L Ng, Amber Johnson, Raphael A Nemenoff, et al.

Critical Reviews in Oncology/Hematology|November 22, 2021

The current landscape of systemic therapy for recurrent glioblastoma: A systematic review of randomized-controlled trialsFrancesco G T Fazzari, Foster Rose, Mehrnoosh Pauls, et al.

Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 14, 2025

Efficacy of cannabinoids for the prophylaxis of chemotherapy-induced nausea and vomiting-a systematic review and meta-analysisRonald Chow, Anna Basu, Jagdeep Kaur, et al.

Eclinicalmedicine|January 16, 2026

Pneumocystis jirovecii pneumonia prophylaxis in patients with glioma receiving concurrent chemoradiation: a systematic review and meta-analysisJason L Jia, Bader Alshamsan, Ana Beltran-Bless, et al.

Pageof 5